SPERSADEX COMP.

5MG/ML+1MG/ML OPH GTT SOL 1X5ML I

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Interruption of marketing 14.02.2019 0180988, 0225168, 0225172
Léky s jinou kombinací antibiotika a kortikoidu
Commercial/marketing reasons 14.08.2019
Interruption of marketing 19.11.2018 Léky s jinou kombinací antibiotika a kortikoidu (Dexa-gentamicin ung, Gentadex gtt sol, Maxitrol gtt sus a Tobradex gtt sus) Manufacturing reasons 30.12.2018
Resumption of marketing 18.07.2018
Interruption of marketing 27.06.2018 Léky s jinou kombinací antibiotika a kortikoidu (Dexa-gentamicin ung, Gentadex gtt sol, Maxitrol gtt sus a Tobradex gtt sus)
Resumption of marketing 27.03.2018
Interruption of marketing 06.02.2018 Léky s jinou kombinací antibiotika a kortikoidu (Dexa-gentamicin ung, Gentadex gtt sol, Maxitrol gtt sus a Tobradex gtt sus)
Placing on the market 15.05.2012

All reports are available in the Overview.

Back to list